Discovering new treatments is critical to improving patient outcomes; however, if these new treatments are not affordable or accessible, their outcomes may have minimal impact for patients and healthcare systems. DIA has helped introduce the integration of value and access discussions, in particular patient perspectives on benefit-risk, earlier and more broadly throughout the product development process and lifecycle management.
Featured Networking and Knowledge Exchange